Search filters

List of works by Jean-Mathieu Beauregard

A CZT-based blood counter for quantitative molecular imaging

scientific article

A dual radiologic contrast agent protocol for 18F-FDG and 18F-FLT PET/CT imaging of mice bearing abdominal tumors.

scientific article published in June 2011

Accuracy and reproducibility of simplified QSPECT dosimetry for personalized Lu-octreotate PRRT

scientific article published on 15 October 2018

Accuracy of 177Lu activity quantification in SPECT imaging: a phantom study

scientific article published on 07 January 2017

Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a 177Lu-DOTATATE patient study

scientific article published on 28 August 2019

An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging

scientific article published in November 2013

Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.

scientific article

Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.

scientific article published on 15 October 2015

Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.

scientific article published on 18 April 2016

Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours

scientific article published on 06 September 2019

Comprehensive SPECT/CT system characterization and calibration for 177Lu quantitative SPECT (QSPECT) with dead-time correction

scientific article published on 14 February 2020

Determination of gamma camera calibration factors for quantitation of therapeutic radioisotopes.

scientific article published on 2 May 2018

Effective specific activities determined by scintillation proximity counting for production runs of [(18)F]FES and 4F-M[(18)F]FES

scientific article published on 01 April 2007

Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesions.

scientific article published in June 2013

FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy.

scientific article published on 3 March 2015

GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome

scientific article published on 13 January 2020

How we read FCH-PET/CT for prostate cancer

scientific article

Impact of dead time on quantitative 177Lu-SPECT (QSPECT) and kidney dosimetry during PRRT

scientific article published on 15 May 2020

Increased Prostate Cancer Glucose Metabolism Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Localised Gleason 8-10 Prostate Cancers Identifies Very High-risk Patients for Early Recurrence and Resistance to Cas

scientific article published on 30 March 2018

Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy.

scientific article published on 23 February 2017

Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma.

scientific article published on 14 March 2018

New developments in the imaging of metastatic prostate cancer

scientific article published on September 2014

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study.

scientific article published on 31 March 2017

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial

scientific article published on 30 November 2018

Personalized kidney dosimetry in 177Lu-octreotate treatment of neuroendocrine tumours: a comparison of kidney dosimetry estimates based on a whole organ and small volume segmentations

scientific article published on 28 August 2019

Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.

scientific article published on August 2010

Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor.

scientific article

Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy

scientific article published on 01 September 2018

Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusion.

scientific article published on 18 July 2013

Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas

scientific article published on 01 September 2015

Steroid Receptor Imaging in Breast Cancer

scientific article published on 01 January 2006

The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy.

scientific article published on 20 September 2011

[18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice.

scientific article